List of Tables
Table 1. Global Taxane Antineoplastic Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Taxane Antineoplastic Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Taxane Antineoplastic Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Taxane Antineoplastic Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Taxane Antineoplastic Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Taxane Antineoplastic Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Taxane Antineoplastic Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Taxane Antineoplastic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Taxane Antineoplastic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Taxane Antineoplastic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Taxane Antineoplastic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Taxane Antineoplastic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxane Antineoplastic Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Taxane Antineoplastic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Taxane Antineoplastic Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Taxane Antineoplastic Drug Sales Market Share by Region (2020-2025)
Table 19. Global Taxane Antineoplastic Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Taxane Antineoplastic Drug Sales Market Share by Region (2026-2031)
Table 21. Global Taxane Antineoplastic Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Taxane Antineoplastic Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Taxane Antineoplastic Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Taxane Antineoplastic Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Taxane Antineoplastic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Taxane Antineoplastic Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Taxane Antineoplastic Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Taxane Antineoplastic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Taxane Antineoplastic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Taxane Antineoplastic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Taxane Antineoplastic Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Taxane Antineoplastic Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Taxane Antineoplastic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Taxane Antineoplastic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Taxane Antineoplastic Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Taxane Antineoplastic Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Taxane Antineoplastic Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Taxane Antineoplastic Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Taxane Antineoplastic Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Taxane Antineoplastic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Taxane Antineoplastic Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Taxane Antineoplastic Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Taxane Antineoplastic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Taxane Antineoplastic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Taxane Antineoplastic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Taxane Antineoplastic Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Taxane Antineoplastic Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Taxane Antineoplastic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Taxane Antineoplastic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Taxane Antineoplastic Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Taxane Antineoplastic Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Taxane Antineoplastic Drug Sales Market Share by Type (2020-2025)
Table 53. Global Taxane Antineoplastic Drug Sales Market Share by Type (2026-2031)
Table 54. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Taxane Antineoplastic Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Taxane Antineoplastic Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Taxane Antineoplastic Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Taxane Antineoplastic Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Taxane Antineoplastic Drug Sales Market Share by Application (2020-2025)
Table 63. Global Taxane Antineoplastic Drug Sales Market Share by Application (2026-2031)
Table 64. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Taxane Antineoplastic Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Taxane Antineoplastic Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Taxane Antineoplastic Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Sanofi US Company Information
Table 76. Sanofi US Description and Business Overview
Table 77. Sanofi US Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi US Taxane Antineoplastic Drug Product
Table 79. Sanofi US Recent Developments/Updates
Table 80. Sun Pharma Company Information
Table 81. Sun Pharma Description and Business Overview
Table 82. Sun Pharma Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharma Taxane Antineoplastic Drug Product
Table 84. Sun Pharma Recent Developments/Updates
Table 85. Oasmia Company Information
Table 86. Oasmia Description and Business Overview
Table 87. Oasmia Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Oasmia Taxane Antineoplastic Drug Product
Table 89. Oasmia Recent Developments/Updates
Table 90. Indena Company Information
Table 91. Indena Description and Business Overview
Table 92. Indena Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Indena Taxane Antineoplastic Drug Product
Table 94. Indena Recent Developments/Updates
Table 95. Bristol-Myers Squibb Company Company Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bristol-Myers Squibb Company Taxane Antineoplastic Drug Product
Table 99. Bristol-Myers Squibb Company Recent Developments/Updates
Table 100. Qilu Pharmaceutical Company Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Qilu Pharmaceutical Taxane Antineoplastic Drug Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Fuxing Medicine Company Information
Table 106. Fuxing Medicine Description and Business Overview
Table 107. Fuxing Medicine Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Fuxing Medicine Taxane Antineoplastic Drug Product
Table 109. Fuxing Medicine Recent Developments/Updates
Table 110. Yuekang Pharmaceutical Company Information
Table 111. Yuekang Pharmaceutical Description and Business Overview
Table 112. Yuekang Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Yuekang Pharmaceutical Taxane Antineoplastic Drug Product
Table 114. Yuekang Pharmaceutical Recent Developments/Updates
Table 115. Hengrui Medicine Company Information
Table 116. Hengrui Medicine Description and Business Overview
Table 117. Hengrui Medicine Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hengrui Medicine Taxane Antineoplastic Drug Product
Table 119. Hengrui Medicine Recent Developments/Updates
Table 120. Huiyu Pharmaceutical Company Information
Table 121. Huiyu Pharmaceutical Description and Business Overview
Table 122. Huiyu Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Huiyu Pharmaceutical Taxane Antineoplastic Drug Product
Table 124. Huiyu Pharmaceutical Recent Developments/Updates
Table 125. Zhendong Pharmaceutical Company Information
Table 126. Zhendong Pharmaceutical Description and Business Overview
Table 127. Zhendong Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhendong Pharmaceutical Taxane Antineoplastic Drug Product
Table 129. Zhendong Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Taxane Antineoplastic Drug Distributors List
Table 133. Taxane Antineoplastic Drug Customers List
Table 134. Taxane Antineoplastic Drug Market Trends
Table 135. Taxane Antineoplastic Drug Market Drivers
Table 136. Taxane Antineoplastic Drug Market Challenges
Table 137. Taxane Antineoplastic Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Taxane Antineoplastic Drug
Figure 2. Global Taxane Antineoplastic Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Taxane Antineoplastic Drug Market Share by Type: 2024 & 2031
Figure 4. Paclitaxel Product Picture
Figure 5. Docetaxel Product Picture
Figure 6. Cabazitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Taxane Antineoplastic Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Taxane Antineoplastic Drug Market Share by Application: 2024 & 2031
Figure 10. Breast Cancer
Figure 11. Stomach Cancer
Figure 12. Ovarian Cancer
Figure 13. Lung Cancer
Figure 14. Testicular Cancer
Figure 15. Cervical Cancer
Figure 16. Endometrial Cancer
Figure 17. Prostate Cancer
Figure 18. Bladder Cancer
Figure 19. Global Taxane Antineoplastic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Taxane Antineoplastic Drug Market Size (2020-2031) & (US$ Million)
Figure 21. Global Taxane Antineoplastic Drug Sales (2020-2031) & (K Units)
Figure 22. Global Taxane Antineoplastic Drug Average Price (US$/Unit) & (2020-2031)
Figure 23. Taxane Antineoplastic Drug Report Years Considered
Figure 24. Taxane Antineoplastic Drug Sales Share by Manufacturers in 2024
Figure 25. Global Taxane Antineoplastic Drug Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest Taxane Antineoplastic Drug Players: Market Share by Revenue in Taxane Antineoplastic Drug in 2024
Figure 27. Taxane Antineoplastic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global Taxane Antineoplastic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America Taxane Antineoplastic Drug Sales Market Share by Country (2020-2031)
Figure 30. North America Taxane Antineoplastic Drug Revenue Market Share by Country (2020-2031)
Figure 31. United States Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe Taxane Antineoplastic Drug Sales Market Share by Country (2020-2031)
Figure 34. Europe Taxane Antineoplastic Drug Revenue Market Share by Country (2020-2031)
Figure 35. Germany Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Taxane Antineoplastic Drug Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific Taxane Antineoplastic Drug Revenue Market Share by Region (2020-2031)
Figure 42. China Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. China Taiwan Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Taxane Antineoplastic Drug Sales Market Share by Country (2020-2031)
Figure 50. Latin America Taxane Antineoplastic Drug Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Taxane Antineoplastic Drug Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Taxane Antineoplastic Drug Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Taxane Antineoplastic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Taxane Antineoplastic Drug by Type (2020-2031)
Figure 60. Global Revenue Market Share of Taxane Antineoplastic Drug by Type (2020-2031)
Figure 61. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Taxane Antineoplastic Drug by Application (2020-2031)
Figure 63. Global Revenue Market Share of Taxane Antineoplastic Drug by Application (2020-2031)
Figure 64. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2020-2031)
Figure 65. Taxane Antineoplastic Drug Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
